Market
Leo Cancer Care raises $65m for upright radiotherapy platform
Leo Cancer Care raised $65 million in funding for its Marie radiotherapy platform, an upright positioning system paired with CT imaging for proton therapy delivery. The system received FDA clearance in July 2025. The funding supports commercialization of the platform, which addresses workflow and patient positioning in radiation oncology.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network